Atypical hemolytic uremic syndrome and mutation analysis of factor H gene in two Tunisian families

International Journal of Nephrology and Renovascular Disease

Volumn 3, Issue , 2010, Pages 85-92

  Habibi, Imen ^a   Sfar, Imen ^a   Alaya, Walid Ben ^a   Methlouthi, Jihen ^b   Ayadi, Abdelkrim ^b   Brahim, Mounira ^b   Blouin, Jacques ^a   Dhagbouj, Raoudha ^a   Rhomdhane, Thouraya Ben ^a   Makhlouf, Mouna ^a   Aouadi, Houda ^a   Ayed Jendoubi, Saloua ^c   Fremeaux Bacchi, Véronique ^b   Sfar, Tahar ^a   Abdallah, Taieb Ben ^a   Ayed, Khaled ^a   Gorgi, Yousr ^a  

^a CHARLES NICOLLE HOSPITAL   (Tunisia)

^b Tahar Sfar University Hospital   (Tunisia)

^c HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

Alternative pathway; Atypical hemolytic uremic syndrome; Complement; Deletion; Factor H; Nucleotide substitution

Indexed keywords

ANTIHYPERTENSIVE AGENT; COMPLEMENT FACTOR H; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FRESH FROZEN PLASMA; FUROSEMIDE; NUCLEOTIDE DERIVATIVE;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; ATYPICAL HEMOLYTIC UREMIC SYNDROME; CLINICAL ARTICLE; COMPLEMENT DEFICIENCY; CONTROLLED STUDY; FEMALE; GENE DELETION; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; HEMOLYTIC UREMIC SYNDROME; HETEROZYGOTE; HOMOZYGOTE; HUMAN; HUMAN TISSUE; HYPERTENSION; INFANT; MALE; PERITONEAL DIALYSIS; PLASMA TRANSFUSION; PROTEIN ANALYSIS; TUNISIA;

EID: 77955530114     PISSN: None     EISSN: 11787058     Source Type: Book Series    
DOI: None     Document Type: Article

References (32)

1. Ruggenenti P, Noris M, Remuzzi G. Thrombotic microangiopathy, haemolytic uremic syndrome and thrombotic thrombocytopenic purpura. Kidney Int. 2001;60:831-846.
2. Zimmerhackl LB. E. coli, antibiotics and the haemolytic-uremic syndrome. N Engl J Med. 2000;342:1990-1991.
3. Constantinescu AR, Bitzan M, Weiss LS et al. Non-enteropathic hemolytic uremic syndrome: Causes and short-term course. Am J Kidney Dis. 2004;43:976-982.
4. Noris M and Remuzzi G. Atypical haemolytic-uremic syndrome. N Engl J Med. 2009;361:1676-1687.
5. Warwicker P, Goodship THJ, Donne RL, et al. Genetic studies into inherited and sporadic haemolytic uraemic syndrome. Kidney Int. 1998;53:836-844.
6. Jozsi M, Heinen S, Hartmann A, et al. Factor H and atypical hemolytic uremic syndrome: mutations in the C-terminus cause structural changes and defective recognition functions. J Am Soc Nephrol. 2006;17:170-177.
7. Neumann HP, Salzmann M, Bohnert-Iwan B, et al. Haemolytic uraemic syndrome and mutations of the factor H gene: a registry-based study of German speaking countries. J Med Genet. 2003;40:676-681.
8. Sanchez-Corral P, Perez-Caballero D, Huarte O, et al. Structural and functional characterization of factor H mutations associated with atypical haemolytic uraemic syndrome. Am J Hum Genet. 2002;71:1285-1295.
9. Skerka C, Zipfel PF. Complement factor H related proteins in immune diseases. Vaccine. 2008;26:9-14.
10. Hocking HG, Herbert AP, Kavanagh D, et al. Structure of N-terminal region of complement factor H and conformational implications of disease-linked sequence variations. J Biological Chem. 2008;283:9475-9487.
11. Schmidt BZ, Fowler NL, Hidvegi T, et al. Distruption of disulfide bonds is responsible for impaired secretion in human complement factor H deficiency. J Biol Chem. 1999;274:11782-11788.
12. Male DA, Ormsby RJ, Ranganathan S, et al. Complement factor H: sequence analysis of 221 kb of human genomic DNA containing the entire FH, FHR-1 and fHR-3. Mol Immunol. 2000;37:41-52.
13. Whaley K, Ruddy S. Modulation of the alternative complement pathways by beta1 H globulin. J Exp Med. 2000;144:1147-1163.
14. Pangburn MK, Schreiber RD, Müller-Eberhard HJ. Human complement C3b inactivator: isolation, characterization, and demonstration of an absolute requirement fort he serum protein beta1 H for cleavage of C3b and C4b in solution. J Exp Med. 2001;146:257-270.
15. Pangburn MK, Schreiber RD, Müller-Eberhard HJ. C3b deposition during activation of the alternative complement pathway and the effect of deposition on the activating surface. J Immunol. 2000;131: 1930-1935.
16. Mayer MM. Complement and complement fixation. In: Kabat EA, Mayer MM, editors. Experimental Immunochemistry. 2nd ed Springfield, IL: Thomas; 1961:133-140.
17. Dragon-Durey MA, Fremeaux-Bacchi V, Loirat C, et al. Heterozygous and homozygous factor H Deficiencies associated with Hemolytic Uremic Syndrome or Membranoproliferative glomerulonephritis: Report and genetic analysis of 16 cases. J Am Soc Nephrol. 2004;15:787-795.
18. Dragon-Durey MA, Blanc C, Marliot F, et al. The high frequency of complement factor H related CFHR1 gene deletion is restricted to specific subgroups of patients with atypical haemolytic uraemic syndrome. J Med Genet. 2009;46:447-450.
19. Caprioli J, Bettinaglio P, Zipfel PF, et al. Italian Registry of Familial and Recurrent HUS/TTP. The molecular basis of familial haemolytic uremic syndrome: mutation analysis of factor H gene reveals a hot spot in short consensus repeat 20. J Am Soc Nephrol. 2001;12:297-307.
20. Sanchez-Corral P, Perez-Caballero D, Huarte O, et al. Structural and functional characterization of factor H mutations associated with atypical haemolytic uremic syndrome. Am J Hum Genet. 2002;71:1285-1295.
21. Perkins SJ, Goodship TH. Molecular modelling of the C-terminal domains of factor H of human complement: a correlation between haemolytic uraemic syndrome and a predicted heparin binding site. J Mol Biol. 2002;316:217-24.
22. Edey MM, Mead PA, Saunders RE, et al. Association of a factor H mutation with hemolytic uremic syndrome following a diarrheal illness. Am J Kidney Dis. 2008;51:487-490.
23. Sellier-Leclerc AL, Fremeaux-Bacchi V, Dragon-Durey MA, et al. Differential Impact of Complement Mutations on clinical characteristics in atypical hemolytic uremic syndrome. J Am Soc Nephrol. 2007;18:2392-2400.
24. Sethi SK, Dragon-Durey MA, Thaker N et al. Hemolytic uremic syndrome due to homozygous factor H deficiency. Clin Exp Nephrol. 2009;13:526-530.
25. Allford SL, Hunt BJ, Rose P et al. Guidelines on the diagnosis and management of the thrombotic microangiopathic haemolytic anaemias. Br J Haematol. 2003;120:556-573.
26. Saland JM, Emre SH, Shneider BL, et al. Favorable long-term outcome after liver - kidney transplant for recurrent hemolytic uremic syndrome associated with a factor H mutation. Am J Transplant. 2006;6:1948-1952.
27. Ault B, Schmidt B, Fowler N, et al. Human factor H deficiency: Mutations in framework cysteine residues and block in H protein secretion and intracellular catabolism. J Biol Chem. 1997;272:25168-25175.
28. Schmidt BZ, Fowler NL, Hidvegi T, et al. Disruption of disulfide bonds is responsible for impaired secretion in human complement factor H deficiency. J Biol Chem. 1999;274:11782-11788.
29. Herbert AP, Ubrin D, Lyon M, et al. Disease-associated sequence variations congregate in a polyanion recognition patch on human factor H revealed in three-dimensional structure. J Biol Chem. 2006;281:15512-16520.
30. Saunders RE, Abar rategui-Gar rido C, Fremeaux-Bacchi V, et al. The interactive factor H-atypical heamolytic ureamic syndrome mutation database and website: update and integration of membrane cofactor protein and factor I mutations with structural models. Hum Mutat. 2007;28:222-234.
31. Jokiranta TS, Jaakola VP, Lebtinen MJ, et al. Structure of complement factor H carboxyl-terminus reveals molecular basis of atypical haemolytic uremic syndrome. EMBO J. 2006;25:1784-1794.
32. Pickering MC, Goicoechea de Jorge E, Martinez-Barricarte R. Spontaneaous heamolytic ureamic syndrome triggered by complement factor H lacking surface recognition domains. J Exp Med. 2007;204:1249-1256.